Neuroprotective role of astaxanthin in hippocampal insulin resistance induced by Aβ peptides in animal model of Alzheimer’s disease SO Rahman, BP Panda, S Parvez, M Kaundal, S Hussain, M Akhtar, ... Biomedicine & Pharmacotherapy 110, 47-58, 2019 | 105 | 2019 |
No association between proton pump inhibitor use and risk of dementia: Evidence from a meta‐analysis S Hussain, A Singh, S Zameer, MC Jamali, H Baxi, SO Rahman, M Alam, ... Journal of gastroenterology and hepatology 35 (1), 19-28, 2020 | 47 | 2020 |
Calcium channel blocker use reduces incident dementia risk in elderly hypertensive patients: a meta-analysis of prospective studies S Hussain, A Singh, SO Rahman, A Habib, AK Najmi Neuroscience Letters 671, 120-127, 2018 | 44 | 2018 |
A novel therapeutic potential of cysteinyl leukotrienes and their receptors modulation in the neurological complications associated with Alzheimer's disease SO Rahman, RK Singh, S Hussain, M Akhtar, AK Najmi European Journal of Pharmacology 842, 208-220, 2019 | 34 | 2019 |
Sacubitril and valsartan protect from experimental myocardial infarction by ameliorating oxidative damage in Wistar rats M Imran, MQ Hassan, MS Akhtar, O Rahman, M Akhtar, AK Najmi Clinical and Experimental Hypertension 41 (1), 62-69, 2019 | 32 | 2019 |
Role of AMP-activated protein kinase on cardio-metabolic abnormalities in the development of diabetic cardiomyopathy: a molecular landscape A Haye, MA Ansari, SO Rahman, Y Shamsi, D Ahmed, M Sharma European Journal of Pharmacology 888, 173376, 2020 | 28 | 2020 |
Preparation, optimization and biological evaluation of gymnemic acid loaded niosomes against streptozotocin-nicotinamide induced diabetic-nephropathy in Wistar rats T Singhal, M Mujeeb, A Ahad, M Aqil, SO Rahman, AK Najmi, ... Journal of Drug Delivery Science and Technology 54, 101328, 2019 | 21 | 2019 |
current quest in natural bioactive compounds for Alzheimer’s disease: Multi-targeted-designed-ligand based approach with preclinical and clinical based evidence A Iqubal, SO Rahman, M Ahmed, P Bansal, MR Haider, MK Iqubal, ... Current Drug Targets 22 (6), 685-720, 2021 | 17 | 2021 |
COVID-19 infection: epidemiology, virology, clinical features, diagnosis and pharmacological treatment A Kaur, V Bhalla, M Salahuddin, SO Rahman, FH Pottoo Current pharmaceutical design 27 (33), 3551-3565, 2021 | 10 | 2021 |
Alogliptin reversed hippocampal insulin resistance in an amyloid-beta fibrils induced animal model of Alzheimer's disease SO Rahman, M Kaundal, M Salman, A Shrivastava, S Parvez, BP Panda, ... European Journal of Pharmacology 889, 173522, 2020 | 10 | 2020 |
Association between insulin and Nrf2 signalling pathway in Alzheimer's disease: A molecular landscape SO Rahman, T Khan, A Iqubal, S Agarwal, M Akhtar, S Parvez, ZA Shah, ... Life Sciences, 121899, 2023 | 6 | 2023 |
An insight into the role of artificial intelligence in the early diagnosis of Alzheimer’s disease RK Verma, M Pandey, P Chawla, H Choudhury, J Mayuren, ... CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2022 | 6 | 2022 |
Effect of statins on amyloidosis in the rodent models of Alzheimer’s disease: Evidence from the preclinical meta-analysis SO Rahman, S Hussain, A Alzahrani, M Akhtar, AK Najmi Brain Research 1749, 147115, 2020 | 6 | 2020 |
Application of contemporary neuroproteomic techniques in unravelling neurological disorders M Khurana, SO Rahman, AK Najmi, FH Pottoo, MS Akhtar Current Protein and Peptide Science 21 (12), 1146-1163, 2020 | 5 | 2020 |
The potential role of probiotics in the Management of Osteoarthritis Pain: current status and future prospects SO Rahman, F Bariguian, A Mobasheri Current Rheumatology Reports 25 (12), 307-326, 2023 | 3 | 2023 |
Levosimendan: mechanistic insight and its diverse future aspects in cardiac care MS Akhtar, MQ Hassan, A Siddiqui, SS Alavudeen, O Afzal, ASA Altamimi, ... Acta Cardiologica 78 (2), 170-187, 2023 | 2 | 2023 |
Structural Proteomics: Detection of Neurodegenerative Protein Modifications M Khurana, SO Rahman, S Agarwal, MS Akhtar, MS Aldughaim, ... Current Protein and Peptide Science 22 (9), 641-655, 2021 | | 2021 |
Neuroprotective role of pioglitazone in reversing hippocampal insulin resistance in Amyloid-β fibrils induced animal model of Alzheimer's disease SO Rahman, S Parvez, BP Panda, AK Najmi IBRO Reports 6, S502, 2019 | | 2019 |
P3‐196: NEUROPROTECTIVE ROLE OF ALOGLIPTIN IN REVERSING AMYLOID‐β FIBRILS INDUCED HIPPOCAMPAL INSULIN RESISTANCE IN ANIMAL MODEL OF ALZHEIMER'S DISEASE SO Rahman, S Pervez, BP Panda, AK Najmi Alzheimer's & Dementia 15, P1004-P1005, 2019 | | 2019 |
Traumatic brain injury and risk of dementia: A meta-analysis of cohort studies using real-world data MS Hussain, SO Rahman, AK Najmi JOURNAL OF NEUROCHEMISTRY 150, 122-122, 2019 | | 2019 |